If you are wondering whether Doximity is attractively priced or just a value trap at its current level, you are in the right place. The stock last closed at US$25.70, with returns of 8.2% over the ...
A number of stocks jumped in the afternoon session after investors appeared to buy the dip amid heightened uncertainty triggered by resurgent inflation fears and escalating geopolitical tensions.
Investors are selling off software stocks, creating buying opportunities for smart investors.
Earlier this month, Doximity reported third-quarter fiscal 2026 results showing revenue of US$185.05 million and net income ...
Doximity, Inc. (NYSE:DOCS) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. The stock given seventh position on our list of best healthcare stocks is Doximity, Inc.
Doximity Inc. deserves preliminary approval for an agreement to pay investors $31 million to settle a proposed securities class action over its professional social network’s metrics, a federal court ...
Doximity, a digital platform for medical professionals, is doubling down on its investment in artificial-intelligence-powered technology to fuel its growth as it boosts its 2024 revenue guidance. The ...
Doximity, a digital platform for medical professionals, cut its workforce by 10%, or 100 employee positions, and downgraded its revenue guidance as it faces economic pressures and slowing sales among ...
Doximity is the most used healthcare social platform in the US, with over 2 million users. Doximity’s business model represents both its biggest strength and threat being excessively focused on a ...
Doximity, a networking platform for healthcare professionals, has entered into an agreement to acquire on-call physician scheduling and messaging app Amion. According to a filing with the Securities ...
The explosion of social networking IPOs over the past decade—Facebook, LinkedIn, Snapchat and more—minted a new class of tech billionaires capitalizing on personal and professional connections through ...
While Doximity CEO Jeff Tangney believes we are still in the “early innings” of the digital healthcare advertising revolution, his social networking company for doctors scored a home run on its first ...